Exact Mass: 760.3279198

Exact Mass Matches: 760.3279198

Found 65 metabolites which its exact mass value is equals to given mass value 760.3279198, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Mono(glucosyluronic acid)bilirubin

(2S,3S,4S,5R,6S)-6-{[3-(2-{[3-(2-carboxyethyl)-5-{[(2E)-4-ethenyl-5-hydroxy-3-methyl-2H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-3-ethenyl-5-hydroxy-4-methyl-2H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C39H44N4O12 (760.2955584)


This compound belongs to the family of Tricarboxylic Acids and Derivatives. These are organic compounds containing three carboxylic acid groups (or salt/ester derivatives thereof).

   

Albanin G

8-{6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl}-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)-4H-chromen-4-one

C45H44O11 (760.2883474)


Albanin G is found in fruits. Albanin G is a constituent of white mulberry (Morus alba) Kuwanon H is a flavonoid isolated from Morus alba, which acts as a potent non-peptide bombesin receptor antagonist. Kuwanon H selectively inhibits binding of gastrin releasing peptide CRP to GRP-preferring recepotr, with a Ki value of 290 nM in cells[1]. Kuwanon H is a flavonoid isolated from Morus alba, which acts as a potent non-peptide bombesin receptor antagonist. Kuwanon H selectively inhibits binding of gastrin releasing peptide CRP to GRP-preferring recepotr, with a Ki value of 290 nM in cells[1].

   

Bilirubin glucuronide

(2S,3S,4S,5R,6R)-5-{[3-(2-{[3-(2-carboxyethyl)-5-{[(2Z)-3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoyl]oxy}-3,4,6-trihydroxyoxane-2-carboxylic acid

C39H44N4O12 (760.2955584)


Bilirubin glucuronide is a natural human metabolite of bilirubin generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Bilirubin glucuronide is a natural human metabolite of bilirubin generated in the liver by UDP glucuonyltransferase.

   

(1R,4S,7S,10R,13R,16S)-13-(1H-Indol-3-ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulfanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

(1R,4S,7S,10R,13R,16S)-13-(1H-indol-3-Ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulphanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

C38H48N8O7S (760.3366498)


   

KuwanonH

4H-1-Benzopyran-4-one, 8-(6-(2,4-dihydroxy-3-(3-methyl-2-butenyl )benzoyl)-5-(2,4-dihydroxyphenyl)-3-methyl-2-cyclohexen-1-yl)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methyl-2-butenyl)-, (1S-(1alpha,5alpha,6beta))-

C45H44O11 (760.2883474)


Kuwanone H is a tetrahydroxyflavone isolated from the plant species of the genus Morus. It has a role as a plant metabolite. It is a tetrahydroxyflavone and a member of resorcinols. Kuwanon H is a natural product found in Morus nigra and Bos taurus with data available. A tetrahydroxyflavone isolated from the plant species of the genus Morus. Kuwanon H is a flavonoid isolated from Morus alba, which acts as a potent non-peptide bombesin receptor antagonist. Kuwanon H selectively inhibits binding of gastrin releasing peptide CRP to GRP-preferring recepotr, with a Ki value of 290 nM in cells[1]. Kuwanon H is a flavonoid isolated from Morus alba, which acts as a potent non-peptide bombesin receptor antagonist. Kuwanon H selectively inhibits binding of gastrin releasing peptide CRP to GRP-preferring recepotr, with a Ki value of 290 nM in cells[1].

   
   
   
   
   

Fokienagarofuran D

(+)-Fokienagarofuran D

C45H44O11 (760.2883474)


   
   
   
   
   

4-Caffeoyl quinic acid, TMS

4-Caffeoyl quinic acid, TMS

C32H64O9Si6 (760.3165774)


   
   

trisorbicillinone A

trisorbicillinone A

C42H48O13 (760.3094758)


   
   

1,2,8,9-Tetrabenzoyl,6-Ac-1,2,6,8,9-Pentahydroxydihydro-beta-agarofuran|Triptogelin A-1

1,2,8,9-Tetrabenzoyl,6-Ac-1,2,6,8,9-Pentahydroxydihydro-beta-agarofuran|Triptogelin A-1

C45H44O11 (760.2883474)


   
   

(?)-(7S,8R,7E)-4-hydroxy-3,3,5,5-tetramethoxy-8,4-oxyneolign-7-ene-7,9,9-triol 7,9-bis-O-beta-D-glucopyranoside|syringylglycerol-8-O-4-sinapyl alcohol ether beta-diglucopyranoside

(?)-(7S,8R,7E)-4-hydroxy-3,3,5,5-tetramethoxy-8,4-oxyneolign-7-ene-7,9,9-triol 7,9-bis-O-beta-D-glucopyranoside|syringylglycerol-8-O-4-sinapyl alcohol ether beta-diglucopyranoside

C34H48O19 (760.2789657999999)


   
   
   

2-(O-beta-D-Glucopyranosyl)-16,25-diacetyl-cucurbitacine I

2-(O-beta-D-Glucopyranosyl)-16,25-diacetyl-cucurbitacine I

C40H56O14 (760.3669876)


   
   

C12-beta-glucuronosyl-bilirubin-IX alpha

C12-beta-glucuronosyl-bilirubin-IX alpha

C39H44N4O12 (760.2955584)


   

C8-beta-glucuronosyl-bilirubin-IX alpha

C8-beta-glucuronosyl-bilirubin-IX alpha

C39H44N4O12 (760.2955584)


   

Galα1-3Galβ1-4[Fucα1-3]GlcNAcβ-Sp

Galα1-3Galβ1-4[Fucα1-3]GlcNAcβ-Sp

C28H48N4O20 (760.2861768)


   

GalNAcα(1-3)[Fucα(1-2)]Galβ(1-4)Glcβ-Sp

GalNAcα(1-3)[Fucα(1-2)]Galβ(1-4)Glcβ-Sp

C28H48N4O20 (760.2861768)


   

Galα(1-3)[Fucα(1-2)]Galβ(1-4)GlcNAcβ-Sp

Galα(1-3)[Fucα(1-2)]Galβ(1-4)GlcNAcβ-Sp

C28H48N4O20 (760.2861768)


   

Bilirubin glucuronate

mono-beta-delta-Glucopyranuronosyl ester 2,17-diethenyl-1,10-19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic acid

C39H44N4O12 (760.2955584)


   

Gala1-3[Fuca1-2]Galb1-3GlcNAcb-Sp

Gala1-3[Fuca1-2]Galb1-3GlcNAcb-Sp

C28H48N4O20 (760.2861768)


   

LPIM1 18:1

2-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C33H61O17P (760.3646186)


   
   

Oxotremorine sesquifumarate

Oxotremorine sesquifumarate

C36H48N4O14 (760.3166868)


   

Pipecuronium bromide

4,4-((2beta,3alpha,5alpha,16beta,17beta)-3,17-Bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium) dibromide

C35H62Br2N4O4 (760.3137532)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents M - Musculo-skeletal system > M03 - Muscle relaxants > M03A - Muscle relaxants, peripherally acting agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant Pipecuronium bromide is a potent long-acting nondepolarizing steroidal neuromuscular blocking agent (NMBA), and a bisquaternary ammonium compound. Pipecuronium bromide is a powerful competitive nAChR antagonist with a Kd of 3.06 μM[1][2][3][4][5].

   

3-QUINUCLIDINYL XANTHENE-9-CARBOXYLATE H

3-QUINUCLIDINYL XANTHENE-9-CARBOXYLATE H

C44H44N2O10 (760.2995804000001)


   

2-O-Methyl Uridine CED Phosphoramidite

2-O-Methyl Uridine CED Phosphoramidite

C40H49N4O9P (760.3236994)


DMT-2'O-Methyl-rU Phosphoramidite (2'-O-Me-U Phosphoramidite) is a 2'-O-Me derivative, and can be used for oligonucleotide synthesis[1][2].

   

Kuwanon H

4H-1-Benzopyran-4-one, 8-(6-(2,4-dihydroxy-3-(3-methyl-2-butenyl )benzoyl)-5-(2,4-dihydroxyphenyl)-3-methyl-2-cyclohexen-1-yl)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methyl-2-butenyl)-, (1S-(1alpha,5alpha,6beta))-

C45H44O11 (760.2883474)


Kuwanon H is a flavonoid isolated from Morus alba, which acts as a potent non-peptide bombesin receptor antagonist. Kuwanon H selectively inhibits binding of gastrin releasing peptide CRP to GRP-preferring recepotr, with a Ki value of 290 nM in cells[1]. Kuwanon H is a flavonoid isolated from Morus alba, which acts as a potent non-peptide bombesin receptor antagonist. Kuwanon H selectively inhibits binding of gastrin releasing peptide CRP to GRP-preferring recepotr, with a Ki value of 290 nM in cells[1].

   

(1R,4S,7S,10R,13R,16S)-13-(1H-Indol-3-ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulfanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

(1R,4S,7S,10R,13R,16S)-13-(1H-indol-3-Ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulphanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

C38H48N8O7S (760.3366498)


   

(2S,3S,4S,5R,6R)-4-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,5,6-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R,6R)-4-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,5,6-trihydroxyoxane-2-carboxylic acid

C39H44N4O12 (760.2955584)


   

(2S,3S,4S,5R,6R)-4-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,5,6-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R,6R)-4-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,5,6-trihydroxyoxane-2-carboxylic acid

C39H44N4O12 (760.2955584)


   

N-{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl}-23-(indol-3-yl)-20-oxo-4,7,10,13,16-pentaoxa-19-azatricosan-1-amide

N-{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl}-23-(indol-3-yl)-20-oxo-4,7,10,13,16-pentaoxa-19-azatricosan-1-amide

C36H52N6O12 (760.3643032)


   

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranoside

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranoside

C32H56O20 (760.3364776000001)


   

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

C32H56O20 (760.3364776000001)


   

5-aminopentyl alpha-L-rhamnopyranosyl-(1->4)-[beta-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-galactopyranoside

5-aminopentyl alpha-L-rhamnopyranosyl-(1->4)-[beta-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-galactopyranoside

C31H56N2O19 (760.3477106)


   

mono(glucosyluronic acid)bilirubin

mono(glucosyluronic acid)bilirubin

C39H44N4O12 (760.2955584)


   
   
   
   
   
   
   
   

2-(2,4-dihydroxyphenyl)-8-[(1r,5s,6s)-6-(2,4-dihydroxyphenyl)-5-(5-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-carbonyl)-3-methylcyclohex-2-en-1-yl]-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

2-(2,4-dihydroxyphenyl)-8-[(1r,5s,6s)-6-(2,4-dihydroxyphenyl)-5-(5-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-carbonyl)-3-methylcyclohex-2-en-1-yl]-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

C45H44O11 (760.2883474)


   

2,6,8,9-tetrakis(acetyloxy)-4-(benzoyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

2,6,8,9-tetrakis(acetyloxy)-4-(benzoyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

C42H48O13 (760.3094758)


   

(8r)-8-ethyl-1,6,8,11-tetrahydroxy-10-{[5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-7-(hydroxymethyl)-7,9,10,11a-tetrahydro-5ah-tetracene-5,12-dione

(8r)-8-ethyl-1,6,8,11-tetrahydroxy-10-{[5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-7-(hydroxymethyl)-7,9,10,11a-tetrahydro-5ah-tetracene-5,12-dione

C39H52O15 (760.3306042)


   

methyl 4-[(7,8-dihydroxy-6-{[6-hydroxy-4-(methoxycarbonyl)-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-hexahydro-2h-pyrano[3,2-d][1,3]dioxin-2-yl)methyl]-5-ethenyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

methyl 4-[(7,8-dihydroxy-6-{[6-hydroxy-4-(methoxycarbonyl)-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-hexahydro-2h-pyrano[3,2-d][1,3]dioxin-2-yl)methyl]-5-ethenyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C34H48O19 (760.2789657999999)


   

(1s,2r,4s,5r,6r,7s,9r,12s)-5-(acetyloxy)-7,12-bis(benzoyloxy)-6-[(benzoyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl benzoate

(1s,2r,4s,5r,6r,7s,9r,12s)-5-(acetyloxy)-7,12-bis(benzoyloxy)-6-[(benzoyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl benzoate

C45H44O11 (760.2883474)


   

(7r,8r,10s)-10-{[(2r,4s,5s,6s)-5-{[(2s,5s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,7,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione

(7r,8r,10s)-10-{[(2r,4s,5s,6s)-5-{[(2s,5s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,7,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione

C38H48O16 (760.2942208)


   

(2r,4s,5r,6s,7s,8r,9r,12r)-12-(acetyloxy)-4,5,7-tris(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

(2r,4s,5r,6s,7s,8r,9r,12r)-12-(acetyloxy)-4,5,7-tris(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

C45H44O11 (760.2883474)